Ambit Biosciences

Biopharmaceutical company discovering and developing kinase inhibitor drugs for oncology and autoimmune diseases

placeSan Diego, California, United States calendar_todayFounded 2000 groups55 employees language ambitbio.com

Registered entities

Innovation

51 patent families (25 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace steady. Cited 7,014 times.

YearFilings
201413
201517
201615
201712
20187
20191
20202
20213
20222
20242
20252
20261

Investor mix

17 investors on record; lead investors include Apposite Capital, Forward Ventures, Gimv, MedImmune Ventures; 4 have since exited.

Investor typeCountShare
Venture capital1165%
Private equity424%
Bank & private debt16%
Other / undisclosed16%
Coming soon